The Silverstein Foundation for Parkinson's with GBA’s Post

The study conducted by Cambridge University suggests a potential link between frequent nightmares and the autoimmune disease Lupus, particularly noting disrupted dreams as a possible early indication of the condition. This discovery may provide a window of opportunity for earlier diagnosis and intervention, potentially leading to more effective treatment approaches for Lupus and shedding light on how neuropsychiatric symptoms can be interconnected with autoimmune diseases. Recognizing nightmares as a symptom could pave the way for improved diagnostic criteria and understanding across various medical conditions. #AutoimmuneDisease #Nightmares #Lupus #DiagnosticCriteria #MentalHealth Read more here: https://lnkd.in/eDa5e3uF BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

💊 Paper to get more insights about Parkinson's disease and related disorders. 🖇 Save it to read.

'Researchers at MIT are thinking outside the box with a new long Covid, chronic Lyme disease study. Dr. Mikki Tal is heading the MIT MAESTRO research study1 which is looking into potential sex differences, predictive diagnostics and immunological, neurological and other mechanisms of chronic illness.' #longcovid #chroniclyme #ticks #biofilms #diagnostics #lymedisease #tickbornediseases #infectiousdisease #lymedisease #lyme #ticks #borrelia #babesia #bartonella https://lnkd.in/emjR-sT5

In our newest #BlogPost, CEO & Founder Stella Sarraf, PhD, reflects on her recent conversation with Dan Doctoroff about the important role #synapses play in neurodegenerative diseases and their shared mission to offer hope to those affected. We are excited about our ongoing trials with #SPG302 in #ALS, and our plans to expand into #AlzheimersDisease and #schizophrenia, where synaptic dysfunction plays a significant role! Read here: https://lnkd.in/erA97avD #ALSawareness #SynapticFunction #PatientsFirst

Did you know that nearly 1 million people in the U.S are living with Parkinson’s Disease? Early detection is crucial as it can help to slow or stop the disease’s progression and ensure proper treatment. LHS is proud to partner with organizations in the neurodegenerative disease space working towards better outcomes for these patients.   CND Life Sciences is a great example of a company truly advancing early detection with their first commercially available Syn-One® Test to detect Parkinson’s disease through a simple skin biopsy. They recently published data in JAMA demonstrating 93-100% accuracy detecting phosphorylated alpha-synuclein in patients with synucleinopathies including dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.   Learn more about how they are addressing key unmet needs by supporting accurate diagnoses for patients:  https://lnkd.in/eKD2QwR     #ParkinsonsDiseaseAwarenessMonth

I am privileged to work with neurodiagnostic innovator, CND Life Sciences, as they improve the diagnosis of patients suffering from #neurodegenerative diseases including #ParkinsonsDisease.

📑 The final report of the JPND - EU Joint-Programme Neurodegenerative Disease Research initiative "Strategizing Transdisciplinary Research Priorities Around the Impact of COVID-19 Control Measures on People with Dementia and Care Partners Living at Home: A 14-Country Perspective", has been published. The report outlines key research priorities that address the impact of COVID-19 control measures on people with dementia and their care partners living at home across 14 countries, and aims to define a comprehensive research strategy to improve policies and support systems in future crises focusing on Europe and the Global South. ➡️ The full report can be accessed here: https://lnkd.in/e-Zd5zTP

🌟 Discover the potential of genome-edited rabbits as a promising alternative model for neurological diseases! 🧠🐇 Read more at: https://lnkd.in/gsJ565t3 #NeurologicalResearch #GenomeEditing #AnimalModels

Astri Arnesen, the President of the European Federation of Neurological Associations, focuses in this MEDtalk on the importance of disease-specific patient journeys for Huntington's disease. In these patient journeys, the development of the European Reference Network for rare neurological diseases describes the complexity and what the healthcare system and the patients should be aware of. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dzTEGiny #EAN24

New Blood Test Could Predict Parkinson’s Disease 7 Years Before Symptoms. Early Detection of Parkinson’s: AI-Powered Blood Test Identifies Biomarkers Years Before Symptoms, Offering Hope for Proactive Management. https://lnkd.in/g-XTGmn7